MedPath

Genotyping 2 SNPs in Chinese Breast Cancers

Conditions
rs185670819 and rs183489969
Registration Number
NCT02886845
Lead Sponsor
Song Hongping
Brief Summary

The purpose of this study is to determine the frequency of two Single Nucleotide Polymorphisms (SNPs) by sanger-sequencing in Breast Cancers and healthy controls .

Detailed Description

Since the 1990s breast cancers incidence of china has increased more than twice as fast as global rates. Chinese patients are responsible for 12.2% of all newly diagnosed breast cancers and 9.6% of all deaths to world breast cancers. Breast cancer is now the second frequently diagnosed cancer and is the leading cause of cancer-related death in Chinese women.

Two of the most prevalent breast cancer susceptibility genes are BRCA1and BRCA2. However,because of population based Genetic heterogeneity, the frequency of BRCA1/BRCA2 mutation is not as high in Caucasian population as in China. Anyway, the mean age at diagnosis of breast cancer in China is almost 10 years younger and more cases are diagnosed before 40 than those in Caucasians. Therefore, it is believed that there are certain specific susceptibility loci in Chinese breast cancers.

In preliminary experiments, investigators found two germline mutations may associate with Chinese breast cancers.

The purpose of the study is to determine the frequency of two germline mutations by sanger-sequencing in a larger sample of Chinese breast cancers

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
2000
Inclusion Criteria
  • Woman aged superior to 18 years old Inform consent signed Woman without breast cancer and family history of cancer
Exclusion Criteria
  • No inform consent signed Patient under guardianship, curatorship Psychosocial disorder

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Genotyping of 2 SNPs ( rs185670819 and rs183489969) in Chinese breast cancer patients and age-matched healthy control women .January of 2019
Secondary Outcome Measures
NameTimeMethod
Both of the 2 SNPs' minor allele frequency or affected ratio shows statistically significant differences between case and control groupsJune of 2019

Trial Locations

Locations (1)

The First Affiliated Hospital of Fourth Military Medical University

🇨🇳

Xi'an, Shaanxi, China

The First Affiliated Hospital of Fourth Military Medical University
🇨🇳Xi'an, Shaanxi, China
hongping song, Ph.D
Contact
+86-29-84771663
Songhp@fmmu.edu.cn
hongping song
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.